Clinical Evaluation of the Photoallergy Potential of Atralin Gel
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
To assess the potential of tretinoin gel 0.05% and its vehicle to produce photoallergic
reactions, measured as skin reactions following induction and challenge.